Symphony Financial’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Symphony Financial's ELV Position: Q2 2026 in Review
Symphony Financial increased its Elevance Health (ELV) stake by 5.2% in Q2 2026, buying an estimated $13.4K and bringing the position to 729 shares worth $283K. The position accounts for 0.03% of the portfolio, ranked #276.
Symphony Financial first reported a position in ELV in Q4 2024 and has held it in 5 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Symphony Financial held 729 shares of Elevance Health worth $283K as of Q2 2026.
- Symphony Financial bought 36 Elevance Health shares in Q2 2026, an estimated $13.4K.
- Elevance Health made up 0.03% of Symphony Financial's portfolio in Q2 2026, its #276 holding.
- Symphony Financial first reported a position in Elevance Health in Q4 2024 and has held it in 5 quarters since.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Symphony Financial's 13F filing for Q2 2026, filed 4 Aug 2026.